SZSE:002755 (China)
Â
Class A
Â¥
18.27
+0.57 (+3.22%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Beijing Aosaikang Pharmaceutical Co Ltd
ISIN : CNE100001X92
Share Class Description:
SZSE:002755: Class ACompare
Compare
Traded in other countries / regions
002755.China Index Membership
SZSE Component Index IPO Date
2015-05-15Description
Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.3 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.73 | |||||
| Interest Coverage | 31.94 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 13.59 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -27.6 | |||||
| 3-Year Book Growth Rate | -1.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 17.91 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.88 | |||||
| 9-Day RSI | 56.67 | |||||
| 14-Day RSI | 57.32 | |||||
| 3-1 Month Momentum % | 37.61 | |||||
| 6-1 Month Momentum % | 33.36 | |||||
| 12-1 Month Momentum % | 73.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.41 | |||||
| Quick Ratio | 3.16 | |||||
| Cash Ratio | 2.77 | |||||
| Days Inventory | 194.58 | |||||
| Days Sales Outstanding | 38.34 | |||||
| Days Payable | 52.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.27 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.05 | |||||
| Operating Margin % | 4.85 | |||||
| Net Margin % | 9.55 | |||||
| FCF Margin % | 16.2 | |||||
| ROE % | 5.61 | |||||
| ROA % | 4.43 | |||||
| ROIC % | 4.98 | |||||
| 3-Year ROIIC % | 373.88 | |||||
| ROC (Joel Greenblatt) % | 29.21 | |||||
| ROCE % | 4.55 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 101.5 | |||||
| Forward PE Ratio | 87 | |||||
| PE Ratio without NRI | 112.09 | |||||
| Shiller PE Ratio | 25.38 | |||||
| Price-to-Owner-Earnings | 630.02 | |||||
| PS Ratio | 9.66 | |||||
| PB Ratio | 5.67 | |||||
| Price-to-Tangible-Book | 7.43 | |||||
| Price-to-Free-Cash-Flow | 60.3 | |||||
| Price-to-Operating-Cash-Flow | 38.97 | |||||
| EV-to-EBIT | 103.45 | |||||
| EV-to-EBITDA | 103.45 | |||||
| EV-to-Revenue | 8.54 | |||||
| EV-to-FCF | 50.15 | |||||
| Price-to-GF-Value | 1.7 | |||||
| Price-to-Projected-FCF | 3.43 | |||||
| Price-to-Graham-Number | 6.09 | |||||
| Price-to-Net-Current-Asset-Value | 10.62 | |||||
| Price-to-Net-Cash | 15.23 | |||||
| Earnings Yield (Greenblatt) % | 0.97 | |||||
| FCF Yield % | 1.63 | |||||
| Forward Rate of Return (Yacktman) % | 1.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Aosaikang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,708.167 | ||
| EPS (TTM) (Â¥) | 0.18 | ||
| Beta | 0.87 | ||
| 3-Year Sharpe Ratio | 0.45 | ||
| 3-Year Sortino Ratio | 0.72 | ||
| Volatility % | 34.43 | ||
| 14-Day RSI | 57.32 | ||
| 14-Day ATR (Â¥) | 1.213792 | ||
| 20-Day SMA (Â¥) | 17.574 | ||
| 12-1 Month Momentum % | 73.86 | ||
| 52-Week Range (Â¥) | 8.33 - 20 | ||
| Shares Outstanding (Mil) | 928.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Aosaikang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Aosaikang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Aosaikang Pharmaceutical Co Ltd Frequently Asked Questions
What is Beijing Aosaikang Pharmaceutical Co Ltd(SZSE:002755)'s stock price today?
The current price of SZSE:002755 is ¥18.27. The 52 week high of SZSE:002755 is ¥20.00 and 52 week low is ¥8.33.
When is next earnings date of Beijing Aosaikang Pharmaceutical Co Ltd(SZSE:002755)?
The next earnings date of Beijing Aosaikang Pharmaceutical Co Ltd(SZSE:002755) is .
Does Beijing Aosaikang Pharmaceutical Co Ltd(SZSE:002755) pay dividends? If so, how much?
Beijing Aosaikang Pharmaceutical Co Ltd(SZSE:002755) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers